By Rob DeWig
When the FDA announced it wouldn’t fully enforce the Drug Supply Chain Security Act (DSCSA) in 2024, opting instead for staggered deadlines, this wasn’t just another delay—it was a strategic shift. Given how serialization data flow from manufacturers down to wholesalers, distributors and pharmacies, expecting full compliance from everyone simultaneously was always unrealistic. A phased approach makes sense because serialization starts at the top, and each supply
APRIL 14, 2025